Last updated: 2026-04-28

Carevoices vs. Glaut: which platform fits pharma-grade AI-moderated research?

Glaut is an AI-moderated-interview methodology vendor (AIMI) that embeds conversational open-ends inside traditional CAWI surveys — ESOMAR-recognized, multi-lingual. Glaut is methodology, not panel and not pharma-grade compliance. Carevoices is the integrated pharma-grade stack: AI-moderated voice/video against a license + NPI verified clinician panel, BAA with no-AI-training clauses, Sunshine Act, stimuli pre-approval, monthly subscription. Choose Glaut for an AI interview layer over surveys; choose Carevoices for the full pharma-grade stack in one platform.

Feature Comparison

Dimension Carevoices Glaut
Product shape Integrated Integrated platform: panel + AI moderation + compliance Methodology-as-software: AI moderator embedded in surveys
Verified clinician panel Verified License + NPI verified at intake (NPPES Registry cross-check) BYO panel from whatever sample provider
AI-moderated voice/video qual depth 5-7 levels Full 30-60 min interviews with 5-7 levels of laddering Conversational open-ends inside CAWI surveys
Pharma BAA infrastructure Pharma-grade Standing template pre-signature with no-AI-training clauses No public BAA template as of mid-2026
Sunshine Act / Open Payments handling Native NPI capture + CMS-format export at panelist intake Not a Glaut function — depends on panel + sponsor
Stimuli pre-approval workflow FDA-ready Versioning + audit trail per stimulus for FDA-relevant content Not a Glaut function
Always-on listening / engagement model Monthly sub Monthly subscription with 50 interviews included Per-survey methodology fee or platform license
Multi-lingual 50+ languages, voice + video + chat Multi-lingual survey integration
ESOMAR methodology recognition Member; methodology aligned with ESOMAR Code ESOMAR Award for Breakthrough Methodology (AIMI)
Subscription scope All-in All-in: recruitment + AI moderation + transcription + de-identification + BAA + compliance package Methodology only — buyer assembles surrounding stack

What's the core difference between Carevoices and Glaut?

Glaut is an AI-moderated interview methodology embedded into surveys; Carevoices is the integrated pharma-grade research stack including verified clinician panel and compliance.

Glaut's flagship product is AIMI (AI-Moderated Interviews) — a methodology that adds conversational, voice-enabled open-ends to traditional CAWI surveys. The AI moderator listens in real time, probes for clarity and elaboration, and produces transcripts organized by thematic clusters. Glaut won the ESOMAR Award for Breakthrough Research Methodology, validating the method itself. The product fits cleanly into market research firms that already own panel relationships, compliance infrastructure, and study design — Glaut adds the AI moderator, not the surrounding stack. Carevoices is structurally different: an integrated research platform that delivers AI-moderated voice and video interviews against its own license + NPI verified clinician panel of 10k+ practitioners, with all healthcare compliance (BAA, HIPAA Safe Harbor de-identification, US data residency, Sunshine Act handling, stimuli pre-approval) built in. The two products serve different parts of the value chain — Glaut is methodology-as-software for firms that already have everything else; Carevoices is the integrated stack for pharma teams who don't want to assemble it themselves.
  • Glaut: AI-moderated open-ends embedded in CAWI surveys; methodology-as-software
  • Carevoices: integrated AI-moderated research platform (panel + AI moderation + compliance)
  • Glaut adds AI moderation to existing market research firm infrastructure
  • Carevoices replaces the need for that infrastructure with one platform

Does Glaut provide the verified clinician panel pharma research requires?

No — Glaut is methodology, not panel. Carevoices delivers a license + NPI verified clinician panel of 10k+ practitioners.

Glaut's AIMI integrates with existing surveys, which means the panel comes from whatever sample provider the market research firm already uses (Cint, Dynata, Reckner, Sermo, M3, etc.). Glaut doesn't run NPPES Registry verification, state license cross-checks, behavioral fingerprinting, or specialty + practice-setting profiling at intake — those are panel-vendor responsibilities. For pharma research where panel verification depth is a procurement requirement, Glaut requires the buyer to bring their own pharma-grade panel. Carevoices verifies every clinician panelist's NPI against the public NPPES Registry, cross-checks state license against state board databases, captures specialty + practice setting + employer attestation at intake, and runs behavioral fingerprinting across interviews. The panel is the cornered resource — generic panel access plus AI moderation isn't equivalent to a purpose-built verified clinician panel with AI moderation built on top.
  • Glaut: BYO panel — integrates with whatever sample provider the firm uses
  • Carevoices: license + NPI verified panel of 10k+ clinicians, NPPES Registry cross-check at intake
  • Verified panel is the cornered resource pharma compliance requires
  • Pharma sponsors increasingly require panel verification as procurement gate

What's the pharma compliance posture comparison?

Glaut hasn't published pharma-specific compliance infrastructure (BAA template, no-AI-training clauses, Sunshine Act handling). Carevoices treats pharma compliance as architecture.

Glaut's compliance posture as of mid-2026 reflects its methodology-vendor positioning — no published BAA template, no public healthcare-specific compliance landing page, no Sunshine Act / Open Payments handling, no stimuli pre-approval workflow for FDA-relevant content. Buyers running pharma research with Glaut would need to verify directly whether BAA can be executed for their engagement and on what timeline. Carevoices builds pharma compliance into architecture: BAA on every healthcare engagement with the AI-specific clauses (no model training on customer PHI, sub-processor cascading to AI model providers including Anthropic / OpenAI / Google, audit rights for AI-training compliance), HIPAA Safe Harbor de-identification on every transcript, US data residency confirmed in writing, Sunshine Act / Open Payments NPI capture and CMS-format export at panelist intake, and stimuli pre-approval workflow with versioning + audit trail for FDA-relevant content.
  • Glaut: no public pharma compliance landing page or BAA template as of mid-2026
  • Carevoices: BAA standing pre-signature with no-AI-training, Sunshine Act NPI capture, stimuli pre-approval — pharma-grade
  • Pharma-grade BAA includes the AI-specific clauses consumer-grade BAAs typically lack
  • Verify Glaut's BAA availability directly for healthcare engagements

How does AI moderator depth compare for pharma qualitative work?

Glaut's AIMI delivers conversational open-ends inside surveys (minutes per respondent); Carevoices delivers full 30-60 minute AI-moderated voice/video interviews with structured laddering.

Glaut's AIMI is engineered for survey integration — open-ends that probe one or two levels deep on specific stimuli, embedded in larger CAWI surveys. The methodology trades full qualitative depth for survey-scale reach: hundreds or thousands of respondents giving short conversational answers rather than dozens giving long-form narrative. This is the right trade-off for brand health trackers, message resonance testing, and concept validation at quantitative scale. Carevoices' AI moderator runs full 30-60 minute voice or video interviews with 5-7 levels of structured laddering — emotional and identity-driven probing depth equivalent to traditional human-moderated qualitative research. The Carevoices AI is calibrated for clinical fluency (knows what 'CAUTI rate', 'Magnet status', 'EHR-go-live' mean) and pharma context (decision drivers, switching triggers, FDA-relevant stimuli reactions). For pharma teams who need full qualitative depth — buying-process studies, message validation with stimuli pre-approval, KOL deep-dives, advisory research — Glaut's survey-embedded model isn't designed to deliver that depth.

Glaut: AI-moderated open-ends embedded in surveys (quant scale, light qual); Carevoices: full AI-moderated voice/video qualitative (deep qual at scale).

When is Glaut the right choice and when is Carevoices?

Glaut for market research firms that already own panel + compliance and want to add AI-moderated open-ends to surveys; Carevoices for pharma teams who need the integrated panel + AI + compliance stack.

Glaut is the right choice for market research firms (Ipsos, Kantar, Nielsen, IQVIA Custom Solutions, etc.) and pharma sponsors with in-house research operations who already own panel relationships, BAA infrastructure, study design, and compliance posture — and need an AI-moderated interview methodology to layer onto existing surveys. The methodology fit is real and the ESOMAR Award validates it. Carevoices is the right choice for pharma marketing, brand, insights, and medical affairs teams who don't want to assemble panel + AI moderation + healthcare compliance + stimuli pre-approval + Sunshine Act handling from separate vendors. The integrated platform delivers full qualitative depth, clinical fluency, and pharma-grade compliance in one engagement structure. Many pharma teams may use both — Glaut inside CAWI tracker programs run by their custom research agency, Carevoices for always-on AI-moderated qualitative inside a monthly subscription.

Glaut for AI-moderated open-ends inside agency-run surveys; Carevoices for the integrated pharma-grade AI-moderated research stack.

Pricing Comparison

Carevoices

Monthly subscription with 50 interviews included

Monthly subscription

  • Subscription includes 50 interviews/month — run any study type
  • Always-on listening capability (no per-survey RFP cycles)
  • Verified clinician panel + AI moderation + transcription + de-identification + BAA + compliance package included
  • Stimuli pre-approval workflow for FDA-relevant content included
  • Sunshine Act / Open Payments NPI capture and CMS-format export included
  • Fielding starts the same week the brief is locked
  • Additional interviews above 50/month available at standard credit rate

Glaut

Methodology license / per-survey methodology fee

Custom quote

  • AI-moderated open-ends embedded in existing CAWI surveys
  • Multi-lingual survey integration
  • ESOMAR Award-recognized methodology
  • Buyer brings panel, BAA, compliance, and surrounding study infrastructure
  • No native pharma compliance package — verify BAA and Sunshine Act handling directly

Which Platform Is Right for You?

Choose Glaut if

  • You're a market research firm that already owns panel + compliance infrastructure
  • You need AI-moderated open-ends embedded in CAWI surveys at quantitative scale
  • You're running brand health trackers or message resonance studies that benefit from light conversational depth
  • Your pharma client procurement allows BYO compliance posture
  • Multi-lingual survey integration is a primary requirement

Choose Carevoices if

  • You need the integrated stack — verified clinician panel + AI moderation + pharma compliance — in one platform
  • Pharma-grade BAA with no-AI-training clauses, Sunshine Act NPI capture, and stimuli pre-approval workflow are required
  • Full 30-60 minute AI-moderated voice/video qualitative depth with 5-7 levels of laddering is the use case
  • License + NPI verified clinician panel is a procurement requirement
  • You want a monthly subscription with 50 interviews included and always-on listening capability across multiple study types
  • Buying-process studies, message validation with FDA-relevant stimuli, KOL deep-dives, or advisory research are the use cases

Switching from Glaut to Carevoices

1

Use case audit

Identify which research currently runs through Glaut. Glaut continues to serve agency-led CAWI tracker programs well; Carevoices replaces the need for separate panel + AI moderation + compliance assembly.

2

BAA + MSA execution

Carevoices BAA template pre-signature with the AI-specific clauses (no model training on PHI, sub-processor cascading). Most agreements execute in 5-10 business days.

3

First subscription month

Use a portion of the included 50 interviews to validate full AI-moderated voice/video depth vs. Glaut's survey-embedded methodology. Fielding starts the same week the brief is locked.

4

Scope expansion

Move always-on AI-moderated qualitative work to Carevoices and run multiple study types (buying-process, message validation, advisory, KOL deep-dives) within the subscription. Retain Glaut where AI-moderated open-ends inside agency-run surveys remain the right fit.

"We were CROs competing on speed alone, but patient research was the bottleneck — we would quote 8-week timelines while sponsors went to bigger firms in the US and Europe. Carevoices changed the math. We ran 1,203 patient interviews in 48 hours for one sponsor, with HIPAA-grade de-identified transcripts delivered straight into our analysis stack, and the AI moderator went deeper than our human moderators on the first round. Sponsors come to us specifically now because we can do depth research at scale — 34% recruitment uplift, 52% retention. We can now compete globally because of Carevoices."

Stephane Nyombaire, CEO, Nivella Health

Key Takeaways

  1. 1
    Product shape

    Glaut is AI-moderated open-ends embedded in surveys (methodology-as-software); Carevoices is the integrated panel + AI moderation + compliance stack.

  2. 2
    Panel

    Glaut: BYO panel from whatever sample provider; Carevoices: license + NPI verified clinician panel of 10k+ practitioners.

  3. 3
    Pharma compliance

    Glaut: no public pharma compliance landing page as of mid-2026; Carevoices: BAA + Sunshine Act + stimuli pre-approval as standard architecture.

  4. 4
    Qualitative depth

    Glaut: short conversational open-ends inside surveys; Carevoices: full 30-60 minute voice/video qualitative with 5-7 levels of laddering.

FAQ

Frequently asked questions

Yes — Glaut received the ESOMAR Award for Breakthrough Research Methodology for AI-Moderated Interviews (AIMIs). The award validates the methodology itself. The award doesn't extend to panel or compliance infrastructure, which Glaut doesn't provide.
As of mid-2026, Glaut hasn't published a healthcare-specific compliance landing page or BAA template. Buyers should verify BAA availability directly. Carevoices includes BAA on every healthcare engagement with the pharma-specific clauses (no-AI-training on PHI, sub-processor cascading) consumer-grade BAAs typically lack.
No — Glaut is methodology that integrates with existing surveys. Panel comes from whatever sample provider the market research firm or sponsor uses. Carevoices delivers a license + NPI verified clinician panel of 10k+ practitioners with NPPES Registry cross-check at intake.
Possibly — Glaut for AI-moderated open-ends inside CAWI tracker programs run by your custom research agency, Carevoices for always-on AI-moderated qualitative work inside a monthly subscription with 50 interviews included. The two platforms can serve different research needs cleanly.
See For Yourself

Ready to see how Carevoices compares?

Walk through your research backlog with the founder. Compliance team welcome — we cover BAA, HIPAA, US data residency, and Sunshine Act handling on the call.

30-min walkthrough
Book a Demo

Walk through your research backlog and see a sample compliant deliverable.

For enterprise + RFP
Contact Sales

Multi-year subscriptions, RFP responses, or top-20 pharma procurement.